The study results showed that the gold nanoparticle–anti-CD133 antibody conjugate could selectively target and deliver the photosensitizer drug to the cancer stem cells, resulting in a significant reduction in their viability compared to nanoparticles without antibody conjugates. The gene discussed is PROM1; the disease is cancer.